Global Stroke Diagnostics and Therapeutics Market Outlook (2014-2022)

Global Stroke Diagnostics and Therapeutics Market Outlook (2014-2022)

  • Published: October 2015
  • ID: SMRC12652

The Global Stroke Diagnostics and Therapeutics Market is valued at $20.5 billion in 2014 and it is expected to reach nearly $34.4 billion by 2022, growing at a CAGR of 6.68% from 2014 to 2022. Stroke is referred to brain attack, this occurs when there is an interruption in the supply of blood to the brain which leads brain cells to die. The factors driving the Global Stroke Diagnostics and Therapeutics Market include technological advancement, growing aging population, and people suffering from diabetes, increasing health expenditure, hypertension and also increasing tobacco users. However factors such as unfavourable reimbursement scenario and high cost of treatments are restraining the market growth.

The Global Stroke Diagnostics and Therapeutics Market is categorized by type, application and geography. By type, the market is segmented into Diagnostics and Therapeutics. The Diagnostics is sub categorized into Magnetic Resonance Imaging (MRI), Computed Tomography Scan (CT scan), Electrocardiography, Carotid Ultrasound, Cerebral Angiography and Others. The Therapeutics is sub segmented into Tissue Plasminogen Activator, Antiplatelet, Antihypertensive and Anticoagulant. On the basis of application, the Stroke Diagnostics and Therapeutics Market is segmented into haemorrhagic stroke and ischemic stroke. Ischemic strokes are caused due to blocked or narrowed arteries that connect to the brain, which results in reduced blood flow in these arteries.

Hemorrhagic stroke is caused on account of the arteries in the brain either leaking blood or bursting open. In the TIAs, the flow of blood to the brain is only disrupted temporarily for a short period of time. By geography, it is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America has the largest market for stroke diagnostics and therapeutics followed by Europe. This is due to the increasing number of patients at the risk of developing stroke, technologically advanced equipment for the diagnosis and treatment of stroke, rise in research and development activities, increasing awareness among people about the causes of stroke, and improved healthcare infrastructure in the region.

The stroke diagnostics and therapeutics market in Asia is expected to witness the high growth rate in the next few years. This is due to growing aging population, evolving R&D activities for drug discovery and development, increasing government support in the form of funding, growing awareness about stroke and its causes, and developing healthcare infrastructure in the region. In addition, growing demographics and economies in the developing countries such as India, China, and Japan are expected to lead the growth in the stroke diagnostics and therapeutics market in Asia.

Some of the prominent players in Global Stroke Diagnostics and Therapeutics Market include Abbott Laboratories, Siemens AG, Stryker Corporation, GE Healthcare, Medtronic plc, Cordis Corporation, Genentech Inc., Boston Scientific Corporation, Coaxia Inc. and Philips Healthcare.

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary               
                      
2 Preface                 
  2.1 Abstract               
  2.2 Research Scope               
  2.3 Research Methodology             
  2.4 Research Sources              
                      
3 Market Trend Analysis               
  3.1 Introduction               
  3.2 Drivers               
  3.3 Restraints               
  3.4 Opportunities               
  3.5 Threats               
                       
4 Porters Five Force Analysis             
  4.1 Bargaining power of suppliers           
  4.2 Bargaining power of buyers             
  4.3 Threat of substitutes             
  4.4 Threat of new entrants             
  4.5 Competitive rivalry              
                      
5  Global Stroke Diagnostics and Therapeutics Market, By Type     
  5.1 Introduction               
  5.2 Diagnostics                
    5.2.1 Magnetic Resonance Imaging (MRI)         
    5.2.2 Computed Tomography Scan (CT scan)         
    5.2.3 Electrocardiography             
    5.2.4 Carotid Ultrasound             
    5.2.5 Cerebral Angiography               
    5.2.6 Others               
  5.3 Therapeutics               
    5.3.1 Tissue Plasminogen Activator           
    5.3.2 Antiplatelet              
    5.3.3 Antihypertensive              
    5.3.4 Anticoagulant             
                      
6 Global Stroke Diagnostics and Therapeutics Market, By Application     
  6.1
Introduction               
  6.2 Haemorrhagic Stroke             
  6.3 Ischemic Stroke               
                      
7 Global Stroke Diagnostics and Therapeutics Market, By Geography     
  7.1 North America               
    7.1.1 US               
    7.1.2 Canada               
  7.2 Europe               
    7.2.1 Germany               
    7.2.2 France               
    7.2.3 Italy               
    7.2.4 UK               
    7.2.5 Spain               
  7.3 Asia Pacific               
    7.3.1 Japan               
    7.3.2 China               
    7.3.3 India               
    7.3.4 Australia               
    7.3.5 New Zealand             
    7.3.6 Rest of Asia             
  7.4 Rest of the World             
    7.4.1 Latin America             
    7.4.2 Middle East             
    7.4.3 Africa               
    7.4.4 Others               
                      
8 Key Developments               
  8.1 Agreements, Partnerships, Collaborations and Joint Ventures      
  8.2 Acquisitions & Mergers             
  8.3 New Product Launch             
  8.4 Expansions               
  8.5 Other Key Strategies             
                      
9 Company Profiling               
  9.1 Abbott Laboratories              
  9.2 Siemens AG               
  9.3 Stryker Corporation             
  9.4 GE Healthcare               
  9.5 Medtronic plc               
  9.6 Cordis Corporation             
  9.7 Genentech Inc.               
  9.8 Boston Scientific Corporation           
  9.9 Coaxia Inc               
  9.10 Philips Healthcare             
                      
List of Tables                 
1 Global Stroke Diagnostics and Therapeutics Market Outlook, By Type (2014-2022) ($MN) 
2 Global Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2014-2022) ($MN) 
3 Global Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2014-2022) ($MN)
4 Global Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan)  (2014-2022) ($MN)
5 Global Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography  (2014-2022) ($MN)
6 Global Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound  (2014-2022) ($MN)
7 Global Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography  (2014-2022) ($MN)
8 Global Stroke Diagnostics and Therapeutics Market Outlook, By Others  (2014-2022) ($MN) 
9 Global Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics  (2014-2022) ($MN) 
10 Global Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2014-2022) ($MN)
11 Global Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet  (2014-2022) ($MN) 
12 Global Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive   (2014-2022) ($MN)
13 Global Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant  (2014-2022) ($MN)
14 Global Stroke Diagnostics and Therapeutics Market Outlook, By Application (2014-2022) ($MN) 
15 Global Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
16 Global Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke  (2014-2022) ($MN)
17 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Type (2014-2022) ($MN) 
18 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2014-2022) ($MN)
19 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2014-2022) ($MN)
20 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan)  (2014-2022) ($MN)
21 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography  (2014-2022) ($MN)
22 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound  (2014-2022) ($MN)
23 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2014-2022) ($MN)
24 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Others  (2014-2022) ($MN)
25 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics  (2014-2022) ($MN)
26 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2014-2022) ($MN)
27 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet  (2014-2022) ($MN)
28 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive   (2014-2022) ($MN)
29 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant  (2014-2022) ($MN)
30 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Application (2014-2022) ($MN)
31 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
32 North America  Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke  (2014-2022) ($MN)
33 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Type (2014-2022) ($MN) 
34 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2014-2022) ($MN) 
35 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2014-2022) ($MN)
36 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan)  (2014-2022) ($MN)
37 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography (2014-2022) ($MN)
38 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound (2014-2022) ($MN)
39 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2014-2022) ($MN)
40 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Others  (2014-2022) ($MN) 
41 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics  (2014-2022) ($MN)
42 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2014-2022) ($MN)
43 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet  (2014-2022) ($MN)
44 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive   (2014-2022) ($MN)
45 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant  (2014-2022) ($MN)
46 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Application (2014-2022) ($MN) 
47 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
48 Europe  Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke  (2014-2022) ($MN)
49 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Type (2014-2022) ($MN) 
50 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2014-2022) ($MN)
51 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2014-2022) ($MN)
52 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan)  (2014-2022) ($MN)
53 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography  (2014-2022) ($MN)
54 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound  (2014-2022) ($MN)
55 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2014-2022) ($MN)
56 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Others  (2014-2022) ($MN) 
57 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics  (2014-2022) ($MN)
58 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2014-2022) ($MN)
59 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet  (2014-2022) ($MN)
60 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive   (2014-2022) ($MN)
61 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant  (2014-2022) ($MN)
62 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Application (2014-2022) ($MN)
63 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
64 Asia Pacific Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke  (2014-2022) ($MN)
65 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Type (2014-2022) ($MN)
66 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Diagnostics (2014-2022) ($MN)
67 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Magnetic Resonance Imaging (MRI) (2014-2022) ($MN)
68 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Computed Tomography Scan (CT scan)  (2014-2022) ($MN)
69 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Electrocardiography  (2014-2022) ($MN)
70 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Carotid Ultrasound  (2014-2022) ($MN)
71 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Cerebral Angiography (2014-2022) ($MN)
72 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Others  (2014-2022) ($MN)
73 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Therapeutics  (2014-2022) ($MN)
74 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Tissue Plasminogen Activator (2014-2022) ($MN)
75 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Antiplatelet  (2014-2022) ($MN)
76 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Antihypertensive   (2014-2022) ($MN)
77 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Anticoagulant  (2014-2022) ($MN)
78 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Application (2014-2022) ($MN)
79 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Haemorrhagic Stroke(2014-2022) ($MN)
80 Rest Of The World Stroke Diagnostics and Therapeutics Market Outlook, By Ischemic Stroke  (2014-2022) ($MN)

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials